US2023256161A9PendingUtilityA9
Methods and Compositions for Treating a Disease Condition in a Subject
Est. expiryOct 15, 2024(expired)· nominal 20-yr term from priority
A61M 5/14276A61N 1/3605A61N 1/36117A61K 31/395A61K 31/4168A61K 31/4188A61K 31/475A61M 2205/054A61N 1/36002A61N 1/05A61P 9/12A61N 1/18
68
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods for treating a disease condition in a subject are provided. The subject methods are characterizing by enhancing at least one symptom of the disease condition in a manner effective to cause the subject to mount a compensatory response effective to treat the disease condition. Also provided are compositions, kits and systems for practicing the subject methods.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of treating a subject for a disease condition, said method comprising:
enhancing at least one symptom of said disease condition in a manner effective to cause said subject to mount a compensatory response effective to treat said disease condition.
2 . The method according to claim 1 , wherein said enhancing comprises applying a stimulus to said subject.
3 . The method according to claim 2 , wherein said stimulus is a pharmacological agent.
4 . The method according to claim 2 , wherein said stimulus is an electrical stimulus.
5 . The method according to claim 1 , wherein said disease condition is a manifestation of an irregularity in a homeostatic pathway.
6 . The method according to claim 5 , wherein said disease condition is manifested by chronic sympathetic bias.
7 . The method according to claim 6 , wherein said disease condition is a cardiovascular disease.
8 . The method according to claim 7 , wherein said cardiovascular disease is hypertension.
9 . The method according to claim 7 , wherein said stimulus is a pharmacological agent.
10 . The method according to claim 9 , wherein said pharmacological agent is an adrenergic agonist.
11 . The method according to claim 1 , wherein said disease condition is a neurological condition.
12 . The method according to claim 11 , wherein said neurological condition is depression.
13 . The method according to claim 12 , wherein said agent is a serotonin antagonist.
14 . The method according to claim 1 , wherein said disease condition is an immune condition.
15 . The method according to claim 14 , wherein said immune condition is asthma.
16 . The method according to claim 15 , wherein said agent is a proinflammatory agent.
17 . The method according to claim 1 , wherein said disease condition is an endocrine system condition.
18 . The method according to claim 17 , wherein said disease condition is diabetes.
19 . The method according to claim 18 , wherein said agent is an insulin blocker.
20 . The method according to claim 1 , wherein said administering is of limited temporal duration.
21 . The method according to claim 1 , wherein said method comprises monitoring said subject.
22 . The method according to claim 21 , wherein said method comprises applying a first stimulus to said subject and monitoring said subject for a response thereto; and applying a second stimulus to said subject, wherein said second stimulus is determined based on said monitored response to said first stimulus.
23 . The method according to claim 22 , wherein said first stimulus is a pharmacological agent.
24 . The method according to claim 22 , wherein said first stimulus is electrical energy.
25 . An algorithm recorded on a computer-readable medium for administering a stimulus to said subject in accordance with method of claim 2 .
26 . A system comprising:
an algorithm recorded on a computer-readable medium for administering a stimulus to a subject according to a method of claim 2 ; and a stimulus producing component.
27 . The system according to claim 26 , wherein said stimulus producing component is a pharmacological agent delivery device.
28 . The system according to claim 27 , wherein said stimulus producing component is an electrical energy applying device.
29 . A kit comprising:
a stimulus producing component; and instructions for a stimulus to a subject according to the method of claim 2 .
30 . The kit according to claim 29 , wherein said stimulus producing component is a pharmacological agent delivery device.
31 . The kit according to claim 29 , wherein said stimulus producing component is an electrical energy applying device.Join the waitlist — get patent alerts
Track US2023256161A9 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.